To evaluate the efficacy, safety, and tolerability for adjunctive treatment of MDD.
- male or female 18-65 years of age
- experiencing symptoms of depression for at least 4 weeks
To evaluate the efficacy, safety, and tolerability for adjunctive treatment of MDD.